TNONNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TNONW
Tenon Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.45−0.25 (-9.26%)
Close on Oct 19, 2026
- Market cap
- $804
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$40.95 (−94.36%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Tenon Medical, Inc. grew revenue 80.3% to $5.31M over the twelve months to Jun 30, 2026. Free cash flow was -$12.08M.
Revenue
$5.31M
+80.3% vs. a year earlier
Operating income
-$12.89M
TTM Q2 2026
Free cash flow
-$12.08M
TTM Q2 2026
EPS, diluted
-$59.50
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $804
- P/E ratio
- –
- Price to sales
- 0.00
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -1502613.24%
Fundamentals
- Revenue
- $5.31M
- Net income
- -$13.70M
- EPS, diluted
- -$59.50
- Free cash flow
- -$12.08M
- Book value per share
- -$5314.02
- Diluted shares
- 0M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$5.31M+80.3% YoY
Gross profit
$3.55M+165.0% YoY
Operating income
-$12.89M
Net income
-$13.70M
EPS, diluted
–
Free cash flow
-$12.08M
Reported periodTrailing twelve months